Integer Holdings (ITGR) Change in Accured Expenses (2010 - 2026)
Integer Holdings' (ITGR) quarterly Change in Accured Expenses came in at -$30.6 million in Q2 2026, down 30.44% year-on-year from -$44.1 million in Q2 2025, and down 1566.36% quarter-over-quarter from $2.1 million in Q4 2025.
Integer Holdings (ITGR) Change in Accured Expenses (2010 - 2026) Analysis & Trends
Integer Holdings has disclosed Change in Accured Expenses across 17 years of filings, most recently posting -$30.6 million for Q2 2026.
- Change in Accured Expenses for Q2 2026 came in at -$30.6 million, down 30.44% year-over-year; the trailing twelve-month figure through Apr 2026 was -$27.4 million (down 914133.33% YoY), and the FY2025 annual result was -$20.3 million, down 553.24% from the prior year.
- Change in Accured Expenses came in at -$30.6 million for Q2 2026 at Integer Holdings, down from $2.1 million in the prior quarter.
- In the past five years, Change in Accured Expenses ranged from a high of $10.8 million in Q3 2024 to a low of -$30.6 million in Q2 2026.
- The 5-year median for Change in Accured Expenses is $507000.0 (2023), against an average of -$2.8 million.
- Peak annual rise in Change in Accured Expenses reached 1838.26% in 2024, while the deepest fall reached 144.77% in 2024.
- Integer Holdings' Change in Accured Expenses stood at -$3.5 million in 2022, then jumped by 114.42% to $507000.0 in 2023, then jumped by 1838.26% to $9.8 million in 2024, then slumped by 78.73% to $2.1 million in 2025, then sank by 1566.36% to -$30.6 million in 2026.
- The last three Change in Accured Expenses figures came in at -$30.6 million (Q2 2026), $2.1 million (Q4 2025), and $953000.0 (Q3 2025), per Business Quant data.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Change in Accured Expenses (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 154.42 Bn | 147.76 Bn | 6.27 Bn | - |
| 2 | Stryker | 118.12 Bn | 115.25 Bn | 3.81 Bn | -654.00 Mn |
| 3 | Medtronic | 101.72 Bn | 93.55 Bn | 5.76 Bn | 703.00 Mn |
| 4 | Boston Scientific | 67.19 Bn | 65.98 Bn | 3.61 Bn | -512.00 Mn |
| 5 | Edwards Lifesciences | 50.69 Bn | 47.02 Bn | 1.29 Bn | -347.10 Mn |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 21.07 Mn |
| 7 | Dexcom | 28.09 Bn | 26.97 Bn | 750.30 Mn | 145.10 Mn |
| 8 | GE HealthCare Technologies | 28.08 Bn | 26.02 Bn | 1.98 Bn | -250.00 Mn |
| 9 | Steris | 19.80 Bn | 19.37 Bn | 697.10 Mn | 74.30 Mn |
| 10 | Integer Holdings | 3.12 Bn | 3.11 Bn | 109.60 Mn | -30.65 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Apr 3, 2026 | -30.65 Mn |
| Apr 3, 2026 | -30.65 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Dec 31, 2025 | 2.09 Mn |
| Sep 26, 2025 | 953,000.00 |
| Sep 26, 2025 | 953,000.00 |
| Jun 27, 2025 | 183,000.00 |
| Jun 27, 2025 | 183,000.00 |
| Mar 28, 2025 | -23.50 Mn |
| Mar 28, 2025 | -23.50 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Dec 31, 2024 | 9.83 Mn |
| Sep 27, 2024 | 10.80 Mn |
| Sep 27, 2024 | 10.80 Mn |
| Jun 28, 2024 | 2.87 Mn |
| Jun 28, 2024 | 2.87 Mn |
| Mar 29, 2024 | -19.03 Mn |
| Mar 29, 2024 | -19.03 Mn |
| Dec 31, 2023 | 507,000.00 |
| Dec 31, 2023 | 507,000.00 |